/ /

  • linkedin
  • Increase Font
  • Sharebar

    6 things you need to know: Genetic markers for glaucoma identified


    TearScience releases LipiScan for rapid HD meibomian imaging

    Morrisville, NC—TearScience has released LipiScan, the first dedicated high definition (HD) gland imager that allows eyecare professionals (ECPs) to efficiently evaluate meibomian glands.

    The new rapid imager was created with end users in mind. LipiScan incorporates patented dynamic meibomian imaging (DMI) technology to produce HD images of meibomian glands. LipiScan allows ECPs to assess meibomian gland structure during routine workups in any practice setting.


    I-MED Pharma introduces new tear osmolarity device

    Montreal—I-MED Pharma has launched i-Pen, a hand-held device designed for a measurement of tear osmolarity.

    I-MED Pharma Vice President Daniel Hofmann estimates that the company’s business model will allow clinicians to recover their capital costs with fewer than 40 patients.

    He anticipates that the i-Pen will be submitted to U.S. Food and Drug Administration (FDA) in 2016 and that it will not require a CLIA waiver.


    Colleen E. McCarthy
    Colleen McCarthy is a freelance writer based in the Cleveland area and a former editor of Optometry Times. She is a 2010 graduate of the ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V